Fig. 3From: MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkersTukey’s box plot of sLOD adjusted, median normaled and log2 transformed (sLMNLT) intensities of MALDI-TOF/MS features at m/z 1832.2 and 1994.9, grouped by the histological-based reclassification described in “Results” section (BPH benign prostatic hyperplasia, Inflam. chronic inflammation, AAH atypical adenomatous hyperplasia, ASAP atypical small acinar proliferation, HGPIN high-grade prostatic intraepithelial neoplasia, PCa prostatic neoplasia)Back to article page